Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.

Min JA, Yoon Y, Lee HJ, Choi J, Kwon M, Kim K, Lee CU, Kim DJ, Yun H.

J Med Virol. 2013 Apr;85(4):575-82. doi: 10.1002/jmv.23523. Epub 2013 Jan 30.

PMID:
23364858
2.

Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.

Anggorowati N, Yano Y, Heriyanto DS, Rinonce HT, Utsumi T, Mulya DP, Subronto YW, Hayashi Y.

J Med Virol. 2012 Jun;84(6):857-65. doi: 10.1002/jmv.23293.

PMID:
22499006
3.

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.

Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.

BMC Public Health. 2011 May 19;11:351. doi: 10.1186/1471-2458-11-351.

4.

High prevalence of HBV and HCV infection among intravenous drug users in Korea.

Yun H, Kim D, Kim S, Kang S, Jeong S, Cheon Y, Joe K, Gwon DH, Cho SN, Jee Y.

J Med Virol. 2008 Sep;80(9):1570-5. doi: 10.1002/jmv.21255.

PMID:
18649342
5.

Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.

Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.

Arch Virol. 2013 Sep;158(9):1889-94. doi: 10.1007/s00705-013-1681-z. Epub 2013 Apr 4.

PMID:
23553454
6.

Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.

Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.

Isr Med Assoc J. 2008 Nov;10(11):775-8.

7.

HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.

Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.

Int J Infect Dis. 2010 Jan;14(1):e28-33. doi: 10.1016/j.ijid.2009.03.002. Epub 2009 May 21.

8.

Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.

Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG; Cyprus IVDU Network., Kostrikis LG.

J Med Virol. 2010 Feb;82(2):263-70. doi: 10.1002/jmv.21690. Erratum in: J Med Virol. 2010 May;82(5):910-1.

PMID:
20029809
9.

Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.

Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B.

J Med Virol. 2013 Oct;85(10):1712-23. doi: 10.1002/jmv.23650. Epub 2013 Jul 19.

PMID:
23868809
10.

Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.

Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.

AIDS. 1996 Mar;10(3):311-7.

PMID:
8882671
11.

Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.

Shapatava E, Nelson KE, Tsertsvadze T, del Rio C.

Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8.

PMID:
16769443
12.

Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.

Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M.

BMC Infect Dis. 2006 Jun 8;6:93.

13.
14.

Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.

Edeh J, Spalding P.

J Public Health Med. 2000 Dec;22(4):531-9.

PMID:
11192282
15.

Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.

Devi KhS, Brajachand N, Singh HL, Singh YM.

J Commun Dis. 2005 Mar;37(1):73-7.

PMID:
16637404
16.

Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.

Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA.

Eur J Epidemiol. 1994 Dec;10(6):687-94.

PMID:
7672048
17.

Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.

Eur J Epidemiol. 1998 Sep;14(6):555-61.

PMID:
9794122
18.

Infection status and risk factors of HIV, HBV, HCV, and syphilis among drug users in Guangdong, China--a cross-sectional study.

Wu J, Huang J, Xu D, Lu C, Deng X, Zhou X.

BMC Public Health. 2010 Nov 1;10:657. doi: 10.1186/1471-2458-10-657.

19.

Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.

Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S.

J Infect Dev Ctries. 2013 Jun 15;7(6):453-67. doi: 10.3855/jidc.2965.

20.

Bloodborne viral infection in Irish injecting drug users.

Smyth BP, Keenan E, O'Connor JJ.

Addiction. 1998 Nov;93(11):1649-56.

PMID:
9926528

Supplemental Content

Support Center